Jove
Visualize
Contact Us

Related Experiment Videos

Osteocyte biology: its implications for osteoporosis.

L F Bonewald1

  • 1Department of Oral Biology, University of Missouri at Kansas City School of Dentistry, Kansas City, MO 64108-2784, USA. bonewaldl@umkc.edu

Journal of Musculoskeletal & Neuronal Interactions
|December 24, 2004
PubMed
Summary

Osteocyte cell death contributes to osteoporosis. CD40Ligand, a molecule found on immune cells, protects bone cells from death, offering potential new osteoporosis therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Force-Loaded Cementocytes Regulate Osteoclastogenesis via S1P/S1PR1/Rac1 Axis.

Journal of dental research·2023
Same author

Muscle secreted factors enhance activation of the PI3K/Akt and β-catenin pathways in murine osteocytes.

Bone·2023
Same author

Taurine, an osteocyte metabolite, protects against oxidative stress-induced cell death and decreases inhibitors of the Wnt/β-catenin signaling pathway.

Bone·2020
Same author

Mechanical regulation of bone homeostasis through p130Cas-mediated alleviation of NF-κB activity.

Science advances·2019
Same author

Case report: Electron microscopic evaluation of bone from a patient treated with cinacalcet hydrochloride, maxacalcitol, and alfacalcidol for hyperparathyroid bone disease with secondary hyperparathyroidism.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same author

The role of the wnt/β-catenin signaling pathway in formation and maintenance of bone and teeth.

The international journal of biochemistry & cell biology·2016
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Bone biology
  • Immunology
  • Cellular and molecular medicine

Background:

  • Osteocyte viability is crucial for bone health.
  • Osteoporosis, characterized by bone loss, may involve osteocyte cell death.
  • Estrogen is known to preserve osteoblast and osteocyte viability.

Purpose of the Study:

  • To identify factors that protect osteoblasts and osteocytes from cell death.
  • To investigate the role of CD40Ligand in preventing bone cell apoptosis.
  • To explore potential therapeutic applications for osteoporosis.

Main Methods:

  • Investigated the protective effects of CD40Ligand on osteoblasts and MLO-Y4 osteocyte-like cells.
  • Exposed cells to apoptosis-inducing agents like glucocorticoids, tumor necrosis factor alpha, and etoposide.
  • Characterized the expression of CD40Ligand and its receptor CD40 on relevant cell types.

Main Results:

  • CD40Ligand demonstrated a protective effect on osteoblasts and osteocyte-like cells against apoptosis.
  • This protection was observed against cell death induced by glucocorticoids, tumor necrosis factor alpha, and etoposide.
  • CD40Ligand is expressed on activated T lymphocytes, dendritic cells, and vascular endothelial cells, while its receptor CD40 is found on epithelium, B cells, and dendritic cells.

Conclusions:

  • CD40Ligand shows promise as a therapeutic agent for osteoporosis.
  • The findings have significant implications for treating post-menopausal and steroid-induced osteoporosis.
  • Targeting the CD40Ligand pathway could be a novel strategy for preserving bone integrity.

Related Experiment Videos